Literature DB >> 2608084

The effects of taurine on pharmacologically induced myotonia.

D Conte Camerino1, A De Luca, M Mambrini, E Ferrannini, F Franconi, A Giotti, S H Bryant.   

Abstract

Taurine reduces the excitability of striated muscle fibers by increasing the membrane conductance to chloride ions (GCl). This action was tested on rats made myotonic by drugs that block GCl by different mechanisms. Experiments were made "in vivo" using electromyographic (EMG) recordings and "in vitro" with intracellular microelectrode recordings from extensor digitorum longus muscle fibers. Taurine did not antagonize the myotonic discharges produced in vivo by anthracene-9-carboxylic acid, nor did it restore GCl lowered in vitro by this agent. However, when myotonia was chronically induced by 20,25 diazacholesterol, taurine given chronically in vivo or acutely in vitro antagonized the EMG myotonia as well as the reduced GCl and increased excitability of single fibers. We conclude that taurine acts directly on chloride channels to modify their kinetics. Our findings suggest that further clinical studies on the use of taurine in muscle disease involving abnormal excitability or chloride channel function will be useful.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2608084     DOI: 10.1002/mus.880121105

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Chloride channel regulation in the skeletal muscle of normal and myotonic goats.

Authors:  S H Bryant; D Conte-Camerino
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

2.  Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor.

Authors:  D Tricarico; M Barbieri; D C Camerino
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Taurine: the appeal of a safe amino acid for skeletal muscle disorders.

Authors:  Annamaria De Luca; Sabata Pierno; Diana Conte Camerino
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

Review 4.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

5.  In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.

Authors:  Jean-François Desaphy; Teresa Costanza; Roberta Carbonara; Diana Conte Camerino
Journal:  Neuropharmacology       Date:  2012-09-18       Impact factor: 5.250

Review 6.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

7.  Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation.

Authors:  S Pierno; D Tricarico; A De Luca; F Campagna; A Carotti; G Casini; D C Conte Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.